DENTSPLY SIRONA Inc
NASDAQ:XRAY
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Price:
28.38 USD
-5.96%
Market Closed
Updated:
May 3, 2024
DENTSPLY SIRONA Inc
Cost of Revenue
|
DENTSPLY SIRONA Inc
Cost of Revenue Peer Comparison
Comparables:
HAE
COO
ALGN
LNTH
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Cost of Revenue
-$1.9B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-3%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cost of Revenue
-$591m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
|
Cooper Companies Inc
NYSE:COO
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-8%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cost of Revenue
-$1.2B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-22%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cost of Revenue
-$586.9m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-11%
|
See Also
What is DENTSPLY SIRONA Inc's Cost of Revenue?
Cost of Revenue
-1.9B
USD
-1.9B
USD
Based on the financial report for Dec 31, 2023, DENTSPLY SIRONA Inc's Cost of Revenue amounts to -1.9B USD.
What is DENTSPLY SIRONA Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-3%
-3%
Over the last year, the Cost of Revenue growth was -4%. The average annual Cost of Revenue growth rates for DENTSPLY SIRONA Inc have been -5% over the past three years , and -3% over the past ten years .
You don't have any saved screeners yet
